DBS just pulled off Singapore’s first “significant risk transfer” on a US$1 billion corporate loan book, and the headline sounds a lot scarier than what actually happened. In this episode, I walk you through why DBS kept every loan, paid outsiders to eat part of the loss if things go wrong, and used that to free up capital for future growth instead of patching a hole. We also tackle the confusing CET1 number that dipped to 16.9%, what that really means versus MAS floors, and why none of this touches the yield hurdle that keeps DBS in Zone 2 Watchlist under a Temporary Yield Constraint. By the end, you will know what to watch as a CPF and SRS investor, and what you can safely ignore the next time a “first-ever deal” headline pops up.
Key takeaways:
DBS transferred part of the credit risk on US$1 billion of loans without selling the loans.
The SRT structure works like insurance, freeing up capital while keeping borrower relationships intact.
DBS’s CET1 ratio dipped to 16.9% but still sits well above regulatory and forensic floors.
The ordinary dividend still falls short of Iggy’s 4.7% yield hurdle once capital returns are stripped out.
DBS remains Zone 2 Watchlist because of income structure, not because of this new capital tool.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
